Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 259368, 11 pages
http://dx.doi.org/10.1155/2014/259368
Research Article

Fenugreek Prevents the Development of STZ-Induced Diabetic Nephropathy in a Rat Model of Diabetes

1Department of Pharmacology, College of Basic Medical Science, Jilin University, Xinmin Street 126, Changchun 130021, China
2Department of Experimental Pharmacology and Toxicology, School of Pharmacy, Jilin University, Fujin Road 1266, Changchun 130021, China
3The Second Hospital of Jilin University, Ziqiang Street 218, Changchun 130041, China

Received 3 February 2014; Accepted 21 April 2014; Published 8 May 2014

Academic Editor: Menaka C. Thounaojam

Copyright © 2014 Yingli Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Dixit, S. Ghaskadbi, H. Mohan, and T. P. A. Devasagayam, “Antioxidant properties of germinated fenugreek seeds,” Phytotherapy Research, vol. 19, no. 11, pp. 977–983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Narender, A. Puri, S. Shweta et al., “4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 2, pp. 293–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. K. T. Roberts, “The potential of fenugreek (Trigonella foenum-graecum) as a functional food and nutraceutical and its effects on glycemia and lipidemia,” Journal of Medicinal Food, vol. 14, no. 12, pp. 1485–1489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Kashihara, Y. Haruna, V. K. Kondeti, and Y. S. Kanwar, “Oxidative stress in diabetic nephropathy,” Current Medicinal Chemistry, vol. 17, no. 34, pp. 4256–4269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Soetikno, K. Watanabe, F. R. Sari et al., “Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats,” Molecular Nutrition and Food Research, vol. 55, no. 11, pp. 1655–1665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. Craven, F. R. DeRubertis, V. E. Kagan et al., “Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes,” Journal of the American Society of Nephrology, vol. 8, no. 9, pp. 1405–1414, 1997. View at Google Scholar
  7. M. F. Melhem, P. A. Craven, and F. R. DeRubertis, “Effects of dietary supplementation of α-Lipoic acid on early glomerular injury in diabetes mellitus,” Journal of the American Society of Nephrology, vol. 12, no. 1, pp. 124–133, 2001. View at Google Scholar · View at Scopus
  8. H. Trachtman, S. Futterweit, J. Maesaka et al., “Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats,” The American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 269, no. 3, pp. F429–F438, 1995. View at Google Scholar · View at Scopus
  9. M. C. Iglesias-De la Cruz, P. Ruiz-Torres, J. Alcamí et al., “Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells,” Kidney International, vol. 59, no. 1, pp. 87–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. B. Lee, M.-R. Yu, Y. Yang, Z. Jiang, and H. Ha, “Reactive oxygen species-regulated signaling pathways in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S241–S245, 2003. View at Google Scholar · View at Scopus
  11. M. K. Phanish, N. A. Wahab, B. M. Hendry, and M. E. C. Dockrell, “TGF-β1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling,” Nephron—Experimental Nephrology, vol. 100, no. 4, pp. E156–E165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Qi, X. Chen, T. S. Polhill et al., “TGF-β1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway,” The American Journal of Physiology—Renal Physiology, vol. 290, no. 3, pp. F703–F709, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Haeri, H. K. Limaki, C. J. B. White, and K. N. White, “Non-insulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats,” Phytomedicine, vol. 19, no. 7, pp. 571–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Kumar, R. K. Kale, and N. Z. Baquer, “Antihyperglycemic and protective effects of Trigonella foenum graecum seed powder on biochemical alterations in alloxan diabetic rats,” European Review for Medical and Pharmacological Science, vol. 16, supplement 3, pp. 18–27, 2012. View at Google Scholar
  15. D. Puri, K. M. Prabhu, G. Dev, S. Agarwal, and P. S. Murthy, “Mechanism of antidiabetic action of compound GII purified from fenugreek (Trigonella foenum graecum) seeds,” Indian Journal of Clinical Biochemistry, vol. 26, no. 4, pp. 335–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Sankar, S. Subhashree, and S. Sudharani, “Effect of Trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type II diabetic rats,” European Review for Medical and Pharmacological Science, vol. 16, supplement 3, pp. 10–17, 2012. View at Google Scholar
  17. U. N. Tripathi and D. Chandra, “The plant extracts of Momordica charantia and Trigonella foenum graecum have antioxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 290–296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. U. N. Tripathi and D. Chandra, “Anti-hyperglycemic and anti-oxidative effect of aqueous extract of momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats,” Indian Journal of Biochemistry and Biophysics, vol. 47, no. 4, pp. 227–233, 2010. View at Google Scholar · View at Scopus
  19. W.-L. Xue, X.-S. Li, J. Zhang, Y.-H. Liu, Z.-L. Wang, and R.-J. Zhang, “Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats,” Asia Pacific Journal of Clinical Nutrition, vol. 16, supplement 1, pp. 422–426, 2007. View at Google Scholar · View at Scopus
  20. W. X. Tang, W. H. Wu, X. X. Zeng et al., “Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney,” Endocrine, vol. 41, pp. 236–247, 2012. View at Publisher · View at Google Scholar
  21. K. E. White and R. W. Bilous, “Estimation of podocyte number: a comparison of methods,” Kidney International, vol. 66, no. 2, pp. 663–667, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ukeda, S. Maeda, T. Ishii, and M. Sawamura, “Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′-1-(phenylamino)-carbonyl-3, 4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase,” Analytical Biochemistry, vol. 251, pp. 206–209, 1997. View at Publisher · View at Google Scholar
  23. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar · View at Scopus
  25. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  26. G. Zhou, C. Li, and L. Cai, “Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor β-independent pathway,” The American Journal of Pathology, vol. 165, no. 6, pp. 2033–2043, 2004. View at Google Scholar · View at Scopus
  27. A. E. Raptis and G. Viberti, “Pathogenesis of diabetic nephropathy,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, supplement 2, pp. S424–S437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Fioretto and M. Mauer, “Histopathology of diabetic nephropathy,” Seminars in Nephrology, vol. 27, no. 2, pp. 195–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. H. Hao, Z. M. Shao, D. Q. Tang et al., “Preventive effects of rutin on the development of experimental diabetic nephropathy in rats,” Life Sciences, vol. 91, pp. 959–967, 2012. View at Publisher · View at Google Scholar
  30. Y. S. Kanwar, J. Wada, L. Sun et al., “Diabetic nephropathy: mechanisms of renal disease progression,” Experimental Biology and Medicine, vol. 233, no. 1, pp. 4–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Gruden, P. C. Perin, and G. Camussi, “Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology,” Current Diabetes Reviews, vol. 1, no. 1, pp. 27–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Aydin, H. Orhan, A. Sayal, M. Özata, G. Şahin, and A. Isi̧mer, “Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control,” Clinical Biochemistry, vol. 34, no. 1, pp. 65–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Kȩdziora-Kornatowska, S. Szram, T. Kornatowski, L. Szadujkis-Szadurski, J. Kȩdziora, and G. Bartosz, “The effect of verapamil on the antioxidant defence system in diabetic kidney,” Clinica Chimica Acta, vol. 322, no. 1-2, pp. 105–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Chauhan and A. Chauhan, “Oxidative stress in Alzheimer's disease,” Pathophysiology, vol. 13, no. 3, pp. 195–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Yuan, J.-C. Zheng, P. Liu, S.-F. Zhang, J.-Y. Xu, and L.-M. Bai, “Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes,” Neuroscience Bulletin, vol. 23, no. 2, pp. 125–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. L. Y. Tan, J. M. Forbes, and M. E. Cooper, “AGE, RAGE, and ROS in diabetic nephropathy,” Seminars in Nephrology, vol. 27, no. 2, pp. 130–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. H. Ugochukwu and M. K. Cobourne, “Modification of renal oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with extracts from Gongronema latifolium leaves,” Clinica Chimica Acta, vol. 336, no. 1-2, pp. 73–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Yamamoto, T. Nakamura, N. A. Noble, E. Ruoslahti, and W. A. Border, “Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 5, pp. 1814–1818, 1993. View at Google Scholar · View at Scopus
  39. S. Chen, B. Jim, and F. N. Ziyadeh, “Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up,” Seminars in Nephrology, vol. 23, no. 6, pp. 532–543, 2003. View at Google Scholar · View at Scopus
  40. S. Goldfarb and F. N. Ziyadeh, “TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy,” Transactions of the American Clinical and Climatological Association, vol. 112, pp. 27–33, 2001. View at Google Scholar · View at Scopus
  41. M. Greener, “Targeting TGF could counter diabetic nephropathy,” Molecular Medicine Today, vol. 6, no. 10, p. 376, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Gupta, M. R. Clarkson, J. Duggan, and H. R. Brady, “Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis,” Kidney International, vol. 58, no. 4, pp. 1389–1399, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Ito, J. Aten, R. J. Bende et al., “Expression of connective tissue growth factor in human renal fibrosis,” Kidney International, vol. 53, no. 4, pp. 853–861, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Q. Nguyen, L. Tarnow, A. Jorsal et al., “Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy,” Diabetes Care, vol. 31, no. 6, pp. 1177–1182, 2008. View at Publisher · View at Google Scholar · View at Scopus